| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000085 | Mitotic g2 phase | Decreases phenotype | PMID:23527032 |
| GO:0000226 | Microtubule cytoskeleton organization | Decreases phenotype | PMID:33823148 |
| GO:0000724 | Double-strand break repair via homologous recombination | Increases phenotype | PMID:24913804 |
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:24812151 |
| GO:0001678 | Cellular glucose homeostasis | Affects phenotype | PMID:38296531 |
| GO:0001755 | Neural crest cell migration | Decreases phenotype | PMID:26238599 |
| GO:0001893 | Maternal placenta development | Decreases phenotype | PMID:32437819 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:24812151; PMID:34420476 |
| GO:0002539 | Prostaglandin production involved in inflammatory response | Increases phenotype | PMID:33823148 |
| GO:0003810 | Protein-glutamine gamma-glutamyltransferase activity | Decreases phenotype | PMID:34420476 |
| GO:0004032 | Alditol:nadp+ 1-oxidoreductase activity | Increases phenotype | PMID:25504687 |
| GO:0004035 | Alkaline phosphatase activity | Increases phenotype | PMID:25304967 |
| GO:0004053 | Arginase activity | Increases phenotype | PMID:34309930 |
| GO:0004063 | Aryldialkylphosphatase activity | Decreases phenotype | PMID:32662911 |
| GO:0004089 | Carbonate dehydratase activity | Decreases phenotype | PMID:34309930 |
| GO:0004364 | Glutathione transferase activity | Decreases phenotype | PMID:25304967; PMID:25504687; PMID:32662911 |
| GO:0004396 | Hexokinase activity | Decreases phenotype | PMID:28266800 |
| GO:0004402 | Histone acetyltransferase activity | Decreases phenotype | PMID:27381264 |
| GO:0004407 | Histone deacetylase activity | Decreases phenotype | PMID:33770205 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:34309930; PMID:34309959 |
| GO:0004602 | Glutathione peroxidase activity | Affects phenotype | PMID:25504687; PMID:28988495; PMID:31760073; PMID:32662911; PMID:34309930; PMID:34309959; PMID:34420476 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:25504687; PMID:28988495; PMID:34309930; PMID:34309959; PMID:34420476; PMID:35090963 |
| GO:0005249 | Voltage-gated potassium channel activity | Decreases phenotype | PMID:26348896 |
| GO:0005391 | P-type sodium:potassium-exchanging transporter activity | Decreases phenotype | PMID:32662911 |
| GO:0006054 | N-acetylneuraminate metabolic process | Affects phenotype | PMID:25304967 |
| GO:0006099 | Tricarboxylic acid cycle | Decreases phenotype | PMID:24442146 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:30404997 |
| GO:0006306 | Dna methylation | Affects phenotype | PMID:28853863 |
| GO:0006309 | Apoptotic dna fragmentation | Affects phenotype | PMID:19060243; PMID:22814014 |
| GO:0006536 | Glutamate metabolic process | Affects phenotype | PMID:37357844 |
| GO:0006629 | Lipid metabolic process | Affects phenotype | PMID:35156134 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:33007364; PMID:33007364; PMID:39147356; PMID:33901630; PMID:34778935; PMID:39147356; PMID:39423997 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:25504687; PMID:26921665; PMID:29968957; PMID:30273971; PMID:32662911; PMID:32662911; PMID:34309959; PMID:33007364; PMID:34309930; PMID:34309959; PMID:37357844 |
| GO:0006750 | Glutathione biosynthetic process | Affects phenotype | PMID:30426164 |
| GO:0006754 | Atp biosynthetic process | Decreases phenotype | PMID:25716160 |
| GO:0006776 | Vitamin a metabolic process | Affects phenotype | PMID:35594946 |
| GO:0006805 | Xenobiotic metabolic process | Affects phenotype | PMID:25745819 |
| GO:0006811 | Monoatomic ion transport | Increases phenotype | PMID:2167745 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:34748853; PMID:35156134 |
| GO:0006879 | Cellular iron ion homeostasis | Affects phenotype | PMID:39147356 |
| GO:0006915 | Apoptotic process | Affects phenotype | PMID:11281642; PMID:17653085; PMID:19006566; PMID:19060243; PMID:19351772; PMID:21067264; PMID:21737646; PMID:24812151; PMID:25130820; PMID:26865186; PMID:29225137; PMID:32167238; PMID:34658283 |
| GO:0006935 | Chemotaxis | Decreases phenotype | PMID:29845424 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:17994530 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:29845424 |
| GO:0006979 | Response to oxidative stress | Affects phenotype | PMID:19006566; PMID:19351772; PMID:20679181 |
| GO:0007049 | Cell cycle | Decreases phenotype | PMID:17653085; PMID:19351772; PMID:21737646 |
| GO:0007204 | Positive regulation of cytosolic calcium ion concentration | Increases phenotype | PMID:28762043 |
| GO:0007625 | Grooming behavior | Decreases phenotype | PMID:35254616; PMID:37207798 |
| GO:0007631 | Feeding behavior | Affects phenotype | PMID:31085223 |
| GO:0008137 | Nadh dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:31760073 |
| GO:0008177 | Succinate dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:31760073 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:33007364; PMID:33007364; PMID:39147356; PMID:39147356 |
| GO:0008217 | Regulation of blood pressure | Decreases phenotype | PMID:20679181 |
| GO:0008219 | Cell death | Increases phenotype | PMID:17184924; PMID:17479365; PMID:22131109; PMID:26378038 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:17351657; PMID:17994530; PMID:19099629; PMID:25130820; PMID:19351772; PMID:19440698; PMID:20646843; PMID:21067264; PMID:21737646; PMID:23562654; PMID:25130820; PMID:25137620; PMID:31711903; PMID:33991534; PMID:34420476 |
| GO:0008284 | Positive regulation of cell population proliferation | Affects phenotype | PMID:25815518 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:22580532; PMID:32949729; PMID:34537371; PMID:34742744; PMID:37210002 |
| GO:0008344 | Adult locomotory behavior | Decreases phenotype | PMID:29778792 |
| GO:0008610 | Lipid biosynthetic process | Increases phenotype | PMID:25716160; PMID:27089845; PMID:30426164 |
| GO:0008611 | Ether lipid biosynthetic process | Decreases phenotype | PMID:29877216 |
| GO:0008652 | Amino acid biosynthetic process | Decreases phenotype | PMID:24442146 |
| GO:0009060 | Aerobic respiration | Decreases phenotype | PMID:25745980 |
| GO:0009100 | Glycoprotein metabolic process | Affects phenotype | PMID:34309930 |
| GO:0009410 | Response to xenobiotic stimulus | Increases phenotype | PMID:34537371 |
| GO:0009448 | Gamma-aminobutyric acid metabolic process | Affects phenotype | PMID:37357844 |
| GO:0009636 | Response to toxic substance | Affects phenotype | PMID:23179753 |
| GO:0010508 | Positive regulation of autophagy | Increases phenotype | PMID:25446377 |
| GO:0010884 | Positive regulation of lipid storage | Increases phenotype | PMID:28762043 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Affects phenotype | PMID:25446377; PMID:25745980; PMID:28762043 |
| GO:0010940 | Positive regulation of necrotic cell death | Increases phenotype | PMID:35543257 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:22580532; PMID:25446377; PMID:25745980; PMID:27015953; PMID:28001369; PMID:28762043 |
| GO:0010977 | Negative regulation of neuron projection development | Increases phenotype | PMID:29261810; PMID:30578912 |
| GO:0014045 | Establishment of endothelial blood-brain barrier | Decreases phenotype | PMID:32240654 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:28988495; PMID:31760073; PMID:32662911; PMID:33007364; PMID:34309930 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:23562654; PMID:25091725; PMID:29225137; PMID:29845424; PMID:30426164 |
| GO:0016477 | Cell migration | Decreases phenotype | PMID:29845424; PMID:34658283 |
| GO:0016505 | Peptidase activator activity involved in apoptotic process | Increases phenotype | PMID:24913804 |
| GO:0016525 | Negative regulation of angiogenesis | Increases phenotype | PMID:37207908 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:31760073; PMID:32662911; PMID:32662911; PMID:34309959; PMID:34309930; PMID:34309959 |
| GO:0019226 | Transmission of nerve impulse | Increases phenotype | PMID:26348896 |
| GO:0019432 | Triglyceride biosynthetic process | Increases phenotype | PMID:30003287 |
| GO:0021542 | Dentate gyrus development | Affects phenotype | PMID:33150595 |
| GO:0030154 | Cell differentiation | Increases phenotype | PMID:23562654; PMID:31711903 |
| GO:0030182 | Neuron differentiation | Decreases phenotype | PMID:22131109; PMID:29775723 |
| GO:0030199 | Collagen fibril organization | Increases phenotype | PMID:24812151; PMID:34309930 |
| GO:0030263 | Apoptotic chromosome condensation | Increases phenotype | PMID:29225137 |
| GO:0030308 | Negative regulation of cell growth | Increases phenotype | PMID:37210002 |
| GO:0031987 | Locomotion involved in locomotory behavior | Increases phenotype | PMID:31760073; PMID:37357844 |
| GO:0032000 | Positive regulation of fatty acid beta-oxidation | Decreases phenotype | PMID:24442146 |
| GO:0032922 | Circadian regulation of gene expression | Increases phenotype | PMID:29229235 |
| GO:0032930 | Positive regulation of superoxide anion generation | Increases phenotype | PMID:28762043 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:25304967; PMID:25504687; PMID:29968957; PMID:30273971; PMID:37357844 |
| GO:0035176 | Social behavior | Decreases phenotype | PMID:29427782; PMID:29510222; PMID:30404997; PMID:32526256; PMID:35594946; PMID:37357844; PMID:29510222; PMID:32526256; PMID:35254616; PMID:35594946; PMID:36535311; PMID:37207798; PMID:37357844 |
| GO:0035640 | Exploration behavior | Decreases phenotype | PMID:32526256; PMID:35594946; PMID:35594946 |
| GO:0035733 | Hepatic stellate cell activation | Increases phenotype | PMID:24812151 |
| GO:0035815 | Positive regulation of renal sodium excretion | Increases phenotype | PMID:28693025 |
| GO:0035936 | Testosterone secretion | Decreases phenotype | PMID:37505509 |
| GO:0036268 | Swimming | Decreases phenotype | PMID:29427782 |
| GO:0036444 | Calcium import into the mitochondrion | Increases phenotype | PMID:31760073 |
| GO:0040018 | Positive regulation of multicellular organism growth | Decreases phenotype | PMID:29427782; PMID:32437819 |
| GO:0042116 | Macrophage activation | Increases phenotype | PMID:28184907 |
| GO:0042129 | Regulation of t cell proliferation | Affects phenotype | PMID:35090963 |
| GO:0042267 | Natural killer cell mediated cytotoxicity | Increases phenotype | PMID:32060585 |
| GO:0042307 | Positive regulation of protein import into nucleus | Decreases phenotype | PMID:24154490 |
| GO:0042554 | Superoxide anion generation | Affects phenotype | PMID:30426164 |
| GO:0042572 | Retinol metabolic process | Affects phenotype | PMID:32526256 |
| GO:0042756 | Drinking behavior | Affects phenotype | PMID:31085223 |
| GO:0042919 | Benzoate transport | Decreases phenotype | PMID:8140053 |
| GO:0043005 | Neuron projection | Decreases phenotype | PMID:37210002 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:25815518; PMID:28762043; PMID:34742744 |
| GO:0043966 | Histone h3 acetylation | Affects phenotype | PMID:22711276; PMID:22723015; PMID:23378038; PMID:24200999; PMID:25769527; PMID:25815518; PMID:27237783; PMID:28743636; PMID:29225137; PMID:29778792; PMID:29845424; PMID:30897286 |
| GO:0043967 | Histone h4 acetylation | Affects phenotype | PMID:24200999; PMID:25769527; PMID:26378038; PMID:29778792; PMID:29845424 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:32167238; PMID:32623605; PMID:33007364; PMID:33901630; PMID:34658283; PMID:34748853; PMID:38296531 |
| GO:0045176 | Apical protein localization | Decreases phenotype | PMID:31368504 |
| GO:0045333 | Cellular respiration | Decreases phenotype | PMID:32623605 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:30273971 |
| GO:0045651 | Positive regulation of macrophage differentiation | Increases phenotype | PMID:28184907 |
| GO:0045665 | Negative regulation of neuron differentiation | Increases phenotype | PMID:29261810 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:22580532; PMID:29845424 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:32949729; PMID:35090963 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:28988495; PMID:32662911; PMID:34309930 |
| GO:0046323 | Glucose import | Increases phenotype | PMID:38296531 |
| GO:0046330 | Positive regulation of jnk cascade | Increases phenotype | PMID:23378038 |
| GO:0046415 | Urate metabolic process | Decreases phenotype | PMID:29968957 |
| GO:0046449 | Creatinine metabolic process | Decreases phenotype | PMID:17994530; PMID:29968957 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:35543257 |
| GO:0047833 | D-sorbitol dehydrogenase (acceptor) activity | Increases phenotype | PMID:25504687 |
| GO:0048021 | Regulation of melanin biosynthetic process | Affects phenotype | PMID:23001511 |
| GO:0048060 | Negative gravitaxis | Decreases phenotype | PMID:29427782 |
| GO:0048266 | Behavioral response to pain | Decreases phenotype | PMID:37357844 |
| GO:0048312 | Intracellular distribution of mitochondria | Affects phenotype | PMID:25446377 |
| GO:0048386 | Positive regulation of retinoic acid receptor signaling pathway | Decreases phenotype | PMID:27693483 |
| GO:0048666 | Neuron development | Decreases phenotype | PMID:35254616 |
| GO:0048672 | Positive regulation of collateral sprouting | Increases phenotype | PMID:23378038 |
| GO:0048863 | Stem cell differentiation | Decreases phenotype | PMID:25393219; PMID:32205227 |
| GO:0048872 | Homeostasis of number of cells | Affects phenotype | PMID:23527032 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:35543257 |
| GO:0050767 | Regulation of neurogenesis | Affects phenotype | PMID:23527032 |
| GO:0050768 | Negative regulation of neurogenesis | Affects phenotype | PMID:24896083 |
| GO:0050885 | Neuromuscular process controlling balance | Affects phenotype | PMID:37357844 |
| GO:0051149 | Positive regulation of muscle cell differentiation | Affects phenotype | PMID:24896083 |
| GO:0051402 | Neuron apoptotic process | Increases phenotype | PMID:37357844 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Decreases phenotype | PMID:19060243; PMID:27089845; PMID:30426164; PMID:31760073 |
| GO:0051897 | Positive regulation of protein kinase b signaling | Decreases phenotype | PMID:25453207 |
| GO:0051938 | L-glutamate import | Affects phenotype | PMID:29778792 |
| GO:0055007 | Cardiac muscle cell differentiation | Decreases phenotype | PMID:31445079 |
| GO:0055072 | Iron ion homeostasis | Affects phenotype | PMID:39147356 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:30426164 |
| GO:0055078 | Sodium ion homeostasis | Increases phenotype | PMID:28693025 |
| GO:0060135 | Maternal process involved in female pregnancy | Decreases phenotype | PMID:32437819 |
| GO:0060322 | Head development | Affects phenotype | PMID:28635121 |
| GO:0060326 | Cell chemotaxis | Decreases phenotype | PMID:34658283 |
| GO:0061029 | Eyelid development in camera-type eye | Decreases phenotype | PMID:29427782 |
| GO:0061518 | Microglial cell proliferation | Increases phenotype | PMID:33823148 |
| GO:0061744 | Motor behavior | Affects phenotype | PMID:33991534 |
| GO:0061890 | Positive regulation of astrocyte activation | Increases phenotype | PMID:33823148 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:17994530; PMID:34420476; PMID:24812151; PMID:34420476 |
| GO:0070368 | Positive regulation of hepatocyte differentiation | Increases phenotype | PMID:25084468 |
| GO:0070577 | Lysine-acetylated histone binding | Increases phenotype | PMID:28743636 |
| GO:0070633 | Transepithelial transport | Decreases phenotype | PMID:8140053 |
| GO:0070932 | Histone h3 deacetylation | Decreases phenotype | PMID:29229235 |
| GO:0070933 | Histone h4 deacetylation | Decreases phenotype | PMID:29229235 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:24486436; PMID:35090963; PMID:39147356 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:32167238; PMID:33007364; PMID:34309930; PMID:34309959; PMID:34748853; PMID:35156134 |
| GO:0090326 | Positive regulation of locomotion involved in locomotory behavior | Decreases phenotype | PMID:28610743 |
| GO:0090398 | Cellular senescence | Increases phenotype | PMID:21067264 |
| GO:0090557 | Establishment of endothelial intestinal barrier | Decreases phenotype | PMID:32240654 |
| GO:0090648 | Response to environmental enrichment | Decreases phenotype | PMID:30404997 |
| GO:0099610 | Action potential initiation | Decreases phenotype | PMID:36375636 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:33007364; PMID:33007364; PMID:39147356; PMID:33901630; PMID:33901630; PMID:39147356; PMID:37046073; PMID:39147356 |
| GO:0140059 | Dendrite arborization | Decreases phenotype | PMID:33991534 |
| GO:0140253 | Cell-cell fusion | Increases phenotype | PMID:37385477 |
| GO:1900017 | Positive regulation of cytokine production involved in inflammatory response | Increases phenotype | PMID:32240654 |
| GO:1900111 | Positive regulation of histone h3-k9 dimethylation | Decreases phenotype | PMID:25815518 |
| GO:1900535 | Palmitic acid biosynthetic process | Increases phenotype | PMID:30003287 |
| GO:1900745 | Positive regulation of p38mapk cascade | Increases phenotype | PMID:23378038 |
| GO:1901216 | Positive regulation of neuron death | Increases phenotype | PMID:24896083; PMID:33823148 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:30273971 |
| GO:1901726 | Negative regulation of histone deacetylase activity | Increases phenotype | PMID:24896083; PMID:27693483 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:27089845; PMID:27381264; PMID:30426164; PMID:31760073 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Affects phenotype | PMID:25745980; PMID:28762043 |
| GO:1903980 | Positive regulation of microglial cell activation | Increases phenotype | PMID:30404997; PMID:31369746 |
| GO:1904105 | Positive regulation of convergent extension involved in gastrulation | Decreases phenotype | PMID:27693483 |
| GO:1904447 | Folate import across plasma membrane | Increases phenotype | PMID:29223574 |
| GO:1904456 | Negative regulation of neuronal action potential | Increases phenotype | PMID:29596924 |
| GO:1904846 | Negative regulation of establishment of bipolar cell polarity | Decreases phenotype | PMID:31368504 |
| GO:1990138 | Neuron projection extension | Increases phenotype | PMID:23378038 |
| GO:1990911 | Response to psychosocial stress | Decreases phenotype | PMID:33823148 |
| GO:1990962 | Xenobiotic transport across blood-brain barrier | Decreases phenotype | PMID:2117062 |
| GO:2000292 | Regulation of defecation | Affects phenotype | PMID:32526256 |
| GO:2000616 | Negative regulation of histone h3-k9 acetylation | Increases phenotype | PMID:36535311 |
| GO:2000617 | Positive regulation of histone h3-k9 acetylation | Increases phenotype | PMID:28184907 |
| GO:2000726 | Negative regulation of cardiac muscle cell differentiation | Increases phenotype | PMID:34537371 |
| GO:2000736 | Regulation of stem cell differentiation | Affects phenotype | PMID:25247782 |
| GO:2000987 | Positive regulation of behavioral fear response | Increases phenotype | PMID:31369746 |
| GO:2001170 | Negative regulation of atp biosynthetic process | Increases phenotype | PMID:29501571; PMID:33147516 |
| GO:2001171 | Positive regulation of atp biosynthetic process | Decreases phenotype | PMID:26921665 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.